Xingcheng Chemphar Co., Ltd. Xingcheng Chemphar Co., Ltd. is specialized in the manufacture of APIs and pharmaceutical intermediates. Located in the burgeoning coastal city of Taizhou, the company has established GMP standard production base and laboratory in surrounding areas. ... Member since 16 July, 2007, China - Zhejiang
Jiangxi Synergy Pharmaceuticals Co., Ltd. Jiangxi Synergy Pharm was set up in Taizhou of ZheJiang Province in 1996 and was re-organized in Jiangxi Province in year of 2003, and we have invited some capital investment from Saniver Limited HongKong in 2005. In terms of the capacity as well as ... Member since 28 August, 2006, China - Jiangxi
Primary Business Type(s): Manufacturer, Importer / Exporter Buy & Sell Offers: 0 - No Current Trade Leads Products: 0 - No Current Products
Smaart Pharma Smaart Pharma is one of the leading API Manufacturing company from India. We offers Quality Products in competitive rates. Member since 19 June, 2009, India - Maharashtra
Primary Business Type(s): Manufacturer Buy & Sell Offers: 0 - No Current Trade Leads Products: 0 - No Current Products
Statistics: Companies: 641,400+, Trade Leads: 160,300+, Products: 104,200+, Contacts / Replies: 8,283,400+ There are currently 38621 users online browsing our B2B network. 4:54 GMT, Friday, November 29, 2024 Privacy Policy Important Notice! TradeHolding.com B2B Network does not provide an escrow service! Any member who asks you to pay for their products by Western Union to an agent of "TradeHolding.com B2B Network" is fraud and should be immediately reported to us. Do not pay anything to any member who states your money will be added to TradeHolding.com safety deposit account!
All Trade Leads / Offers / Products / Company Profiles / Images and other user-posted contents are posted by the user and BR.TradeHolding.com and TradeHolding.com B2B Network shall not be held liable for any such content. However, TradeHolding.com B2B Network respects the intellectual property, copyright, trademark, trade secret or any other personal or proprietary third party rights and expects the same from others. For concerns, please contact us.